Balsalazide Disodium Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules
Available Strengths: 750 mg, 1,050 mg
Reference Brands: Colazal (USA), Giazo (USA)
Category:
Gastrointestinal Drugs
Balsalazide disodium is available in Tablets, Capsules
and strengths such as 750 mg, 1,050 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Balsalazide disodium is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Balsalazide disodium can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Balsalazide disodium is an anti-inflammatory medication used for the treatment of inflammatory bowel disease, particularly mild to moderate ulcerative colitis. It is a prodrug that is converted by colonic bacteria into mesalazine (5-aminosalicylic acid), the active compound that works locally in the colon to reduce inflammation and maintain remission. Balsalazide is available in oral formulations such as capsules and tablets, as well as rectal formulations like enemas and suppositories, allowing targeted delivery to affected areas of the gastrointestinal tract.
In the United States, Balsalazide is marketed under the brand names Giazo and Colazal, while in the United Kingdom, it is sold as Colazide. Generic versions are also widely available in the US, providing additional options for patients. The drug’s targeted mechanism of action minimizes systemic absorption, helping to reduce side effects while effectively controlling the chronic inflammation associated with ulcerative colitis. Its use helps induce remission, prevent flare-ups, and improve quality of life for patients with inflammatory bowel disease.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing